8-K: XWELL Inc. Reports 13% Revenue Growth in Third Quarter 2024, Focuses on Profitability

XWELL, Inc. announced a 13% revenue increase for the third quarter of 2024 and a 16% increase for the nine-month period, alongside significant reductions in operating expenses.

Summary

• XWELL, Inc. reported a 13% increase in revenue for the third quarter of 2024, reaching $8.4 million, compared to $7.5 million in the same quarter of 2023.
• The company's revenue for the nine-month period ending September 30, 2024, grew by approximately 16% compared to the same period in 2023.
• XWELL has focused on reducing costs, achieving a 6% reduction in cost of sales, a 5% reduction in general and administrative expenses, and a 35% reduction in total operating expenses for the nine-month period compared to 2023.
• The company's operating loss decreased significantly to $4.8 million in Q3 2024, compared to $12.1 million in Q3 2023.
• Net loss attributable to XWELL was $4.8 million for the third quarter of 2024, compared to $11.5 million for the same period in 2023.
• XWELL completed a registered direct offering in August 2024, raising $1.4 million in gross proceeds at a premium to market.
• As of September 30, 2024, XWELL had $4.4 million in cash and cash equivalents, $11.7 million in marketable securities, and no long-term debt.
• XpresSpa contributed $4.9 million to the Q3 revenue, while XpresTest, including biosurveillance and HyperPointe, contributed $3.1 million, and Naples Wax Center contributed $0.4 million.

Sentiment

Score: 7

Explanation: The document shows positive trends in revenue growth and cost reduction, along with a strategic expansion plan. However, the company is still operating at a loss, which tempers the overall positive sentiment.

Positives

• XWELL demonstrated strong revenue growth in both the third quarter and the nine-month period of 2024.
• The company has made significant progress in reducing its cost structure across various expense categories.
• XWELL's operating loss has substantially decreased, indicating improved financial performance.
• The company successfully raised capital through a registered direct offering at a premium to market.
• XWELL has a solid cash position and no long-term debt.
• The company is expanding its footprint with new XpresSpa and Naples Wax Center locations.

Negatives

• Despite improvements, XWELL still reported a net loss of $4.8 million for the third quarter of 2024.
• Salaries and benefits expenses increased in Q3 2024 compared to Q3 2023 due to the absence of the Employee Retention Credit (ERC) which reduced expenses in the prior year.
• General and administrative expenses increased in Q3 2024 due to over $2.0 million in extraordinary legal expenses.

Risks

• The company's future performance is subject to risks and uncertainties, as detailed in their SEC filings.
• Forward-looking statements are not guarantees of future performance, and actual results may vary materially.
• The company's ability to achieve profitability depends on continued cost reductions and revenue growth.
• The company is exposed to risks associated with the expansion of new locations and the execution of its growth strategy.

Future Outlook

XWELL believes it is well-positioned for a strong 2025 and remains confident that its consistent strategy execution will benefit its stakeholders. The company is planning to open new locations for both XpresSpa and Naples Wax Center.

Management Comments

• We're pleased with our third quarter and year-to-date performance, marked by the successful implementation of growth and productivity initiatives across our organization, said Ezra Ernst, CEO of XWELL.
• As we focus on achieving healthy, sustainable growth and returning to profitability, we're seeing considerable opportunities across all of our brands.
• Looking forward, we believe we're well-positioned for a strong 2025, and we remain confident that our consistent strategy execution will benefit our customers, partners, employees, and shareholders.

Industry Context

XWELL's focus on travel wellness and biosurveillance aligns with growing trends in health and safety awareness, particularly in transportation hubs. The company's expansion into out-of-airport locations also reflects a broader trend of wellness services becoming more accessible to the general public.

Comparison to Industry Standards

• XWELL's 13% revenue growth in Q3 2024 is a positive sign, but it's important to compare this to other travel retail and wellness companies. For example, companies like Dufry and SSP Group, which operate in the travel retail space, have seen varying growth rates depending on the region and specific market conditions.
• The 35% reduction in operating expenses is significant and suggests a strong focus on efficiency. This is a key area where XWELL needs to outperform competitors like Massage Envy or other spa chains, which often have higher operating costs due to staffing and location expenses.
• The expansion of XpresSpa into Penn Station is a strategic move to capture a high-traffic location, similar to how other retailers like Hudson News or Starbucks target transportation hubs. The success of this venture will depend on XWELL's ability to manage costs and deliver a high-quality customer experience.
• The biosurveillance partnership with the CDC and Ginkgo Bioworks is a unique aspect of XWELL's business, differentiating it from traditional wellness companies. This positions XWELL to capitalize on the growing demand for health and safety solutions in travel, similar to how companies like Abbott and Thermo Fisher Scientific have benefited from increased testing and surveillance needs.

Stakeholder Impact

• Shareholders may view the revenue growth and cost reductions positively, but the continued net loss may be a concern.
• Employees may benefit from the company's growth and expansion plans.
• Customers will have access to more wellness services with the expansion of XpresSpa and Naples Wax Center locations.
• Partners may see increased opportunities for collaboration with XWELL's growth.
• Creditors may be reassured by the company's improved financial performance and cash position.

Next Steps

• XWELL plans to open an XpresSpa location in New York City's Penn Station in 2025.
• The company is in the process of executing additional leases for Naples Wax Center in Florida, forecasting approximately 10 out-of-airport locations in 2025.
• XWELL will continue to focus on reducing its cost structure and returning to profitability.

Key Dates

Keywords

XWELL, XpresSpa, Naples Wax Center, XpresCheck, HyperPointe, Financial Results, Revenue Growth, Cost Reduction, Operating Loss, Biosurveillance, Wellness, Travel Retail, Airport Services